
The CTLA4:B7-1 TR-FRET Assay is designed to measure the inhibition of CTLA4 binding to B7-1 in a homogeneous 384 reaction format. This FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; a sample containing biotinylated CTLA4, B7-1 protein, anti-His Tb donor, dye-labeled acceptor, and an inhibitor is incubated for two hours. Then, the fluorescence intensity is measured using a fluorescence reader.

V poslednom obdobi coraz castejsie pocuvame o viruse RSV. Spolu s virusom chripky a koronavirusom pa...
Čítať viac
V roku 2007 získali Nobelovu cenu za fyziológiu alebo medicínu Mario R. Capecchi (USA), Sir Martin E...
Čítať viac
Trh s farmaceutickymi a biologickymi liekmi ponuka siroku skalu pripravkov urcenych na liecbu mnohyc...
Čítať viac